{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:00:55Z","timestamp":1790409655783,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["7254421"],"award-info":[{"award-number":["7254421"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Beijing Natural Science Foundation","doi-asserted-by":"publisher","award":["L259080"],"award-info":[{"award-number":["L259080"]}],"id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["GSE214695"],"award-info":[{"award-number":["GSE214695"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["YG28QKC6SI"],"award-info":[{"award-number":["YG28QKC6SI"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Natural Science Foundation of Heilongjiang Province","doi-asserted-by":"publisher","award":["JJ2025PL1632"],"award-info":[{"award-number":["JJ2025PL1632"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202728"],"award-info":[{"award-number":["82202728"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82472447"],"award-info":[{"award-number":["82472447"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioactmat.2026.04.034","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T05:58:52Z","timestamp":1779775132000},"page":"817-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Bone targeted microenvironment actuated engineered exosomes for precision therapy of IBD associated bone loss"],"prefix":"10.1016","volume":"64","author":[{"given":"Jiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2289-2794","authenticated-orcid":false,"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taojin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siliang","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weier","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pincong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simiao","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengbin","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3239-6567","authenticated-orcid":false,"given":"Ying","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6163-7716","authenticated-orcid":false,"given":"Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haile","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.bioactmat.2026.04.034_bib1","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/s41575-025-01097-1","article-title":"The global burden of inflammatory bowel disease: from 2025 to 2045","volume":"22","author":"Kaplan","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"8","key":"10.1016\/j.bioactmat.2026.04.034_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41579-025-01163-0","article-title":"Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities","volume":"23","author":"Iliev","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.04.034_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/gutjnl-2025-336402","article-title":"Global consensus statement on the management of pregnancy in inflammatory bowel disease","volume":"75","author":"Mahadevan","year":"2026","journal-title":"Gut"},{"issue":"39","key":"10.1016\/j.bioactmat.2026.04.034_bib4","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.3748\/wjg.v20.i39.14087","article-title":"Managing osteoporosis in ulcerative colitis: something new?","volume":"20","author":"Piodi","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.bioactmat.2026.04.034_bib5","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1093\/ibd\/izaf063","article-title":"Incidence of osteoporosis and osteopenia in newly diagnosed inflammatory bowel disease: a population-based cohort study","volume":"31","author":"Attauabi","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.04.034_bib6","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jocd.2019.07.009","article-title":"Bone health in patients with inflammatory bowel diseases","volume":"23","author":"Chedid","year":"2020","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bioactmat.2026.04.034_bib7","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.57187\/s.3407","article-title":"Bone health in patients with inflammatory bowel disease","volume":"154","author":"Kreienbuehl","year":"2024","journal-title":"Swiss Med. Wkly."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s41043-025-00946-8","article-title":"Prevalence of osteoporosis in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"44","author":"Marzban","year":"2025","journal-title":"J. Health Popul. Nutr."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.04.034_bib9","doi-asserted-by":"crossref","first-page":"254","DOI":"10.5217\/ir.2024.00185","article-title":"Gut, bone, and muscle: the triad of osteosarcopenia in inflammatory bowel disease","volume":"23","author":"Sharma","year":"2025","journal-title":"Intestinal Res."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.04.034_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/nrd3669","article-title":"Inflammatory bone loss: pathogenesis and therapeutic intervention","volume":"11","author":"Redlich","year":"2012","journal-title":"Nature Reviews Drug Discovery"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cgh.2013.08.024","article-title":"Efficacy and safety of medical therapy for low bone mineral density in patients with inflammatory bowel disease: a meta-analysis and systematic review","volume":"12","author":"Melek","year":"2014","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioactmat.2026.04.034_bib12","first-page":"71","article-title":"An olsalazine nanoneedle-embedded inulin hydrogel reshapes intestinal homeostasis in inflammatory bowel disease","volume":"33","author":"Zhang","year":"2024","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib13","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12951-023-02045-4","article-title":"Oral hydrogel nanoemulsion co-delivery system treats inflammatory bowel disease via anti-inflammatory and promoting intestinal mucosa repair","volume":"21","author":"Lei","year":"2023","journal-title":"J. Nanobiotechnol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib14","article-title":"Exosome-based bone-targeting drug delivery alleviates impaired osteoblastic bone formation and bone loss in inflammatory bowel diseases","volume":"4","author":"Guo","year":"2023","journal-title":"Cell Rep. Med."},{"issue":"7","key":"10.1016\/j.bioactmat.2026.04.034_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.115953","article-title":"FTO SUMOylation regulates the differentiation of bone marrow mesenchymal stromal cells in inflammatory bowel disease-induced bone loss","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioactmat.2026.04.034_bib16","first-page":"26","article-title":"Combination therapy using intestinal organoids and their extracellular vesicles for inflammatory bowel disease complicated with osteoporosis","volume":"53","author":"Wang","year":"2025","journal-title":"J. Orthop. Transl."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41413-024-00381-1","article-title":"Bifidobacterium animalis subsp. lactis A6 ameliorates bone and muscle loss via modulating gut microbiota composition and enhancing butyrate production","volume":"13","author":"Chen","year":"2025","journal-title":"Bone Res."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.04.034_bib18","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.3390\/ijms24065161","article-title":"Pivotal role of intestinal microbiota and intraluminal metabolites for the maintenance of gut-bone physiology","volume":"24","author":"Gr\u00fcner","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","article-title":"ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease","volume":"18","author":"Gordon","year":"2024","journal-title":"J. Crohns Colitis"},{"key":"10.1016\/j.bioactmat.2026.04.034_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/1498293","article-title":"Risk factors for worsening of bone loss in patients newly diagnosed with inflammatory bowel disease","volume":"2022","author":"Yin","year":"2022","journal-title":"Gastroenterol. Res. Pract."},{"issue":"8","key":"10.1016\/j.bioactmat.2026.04.034_bib21","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.3390\/biomedicines10081903","article-title":"Characterization of maladaptive processes in acute, chronic and remission phases of experimental colitis in C57BL\/6 mice","volume":"10","author":"Gelmez","year":"2022","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.bioactmat.2026.04.034_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ibd\/izab174","article-title":"Characterization of skeletal phenotype and associated mechanisms with chronic intestinal inflammation in the Winnie mouse model of spontaneous chronic colitis","volume":"28","author":"Al Saedi","year":"2022","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bioactmat.2026.04.034_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2026.1729584","article-title":"Bone turnover markers in patients with inflammatory bowel disease in remission: a cross-sectional comparison of anti-TNF\u03b1 therapy with conventional maintenance therapy","volume":"13","author":"Jarmakiewicz-Czaja","year":"2026","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib24","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.cell.2019.12.016","article-title":"Enteric nervous system-derived IL-18 orchestrates mucosal barrier immunity","volume":"180","author":"Jarret","year":"2020","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.bioactmat.2026.04.034_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2024.06.001","article-title":"A metabolic switch orchestrated by IL-18 and the cyclic dinucleotide cGAMP programs intestinal tolerance","volume":"57","author":"Mertens","year":"2024","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib26","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41467-022-28478-3","article-title":"IL-22 initiates an IL-18-dependent epithelial response circuit to enforce intestinal host defence","volume":"13","author":"Chiang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.034_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.752546","article-title":"NLRP3 inflammasome: a new target for prevention and control of osteoporosis?","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.bioactmat.2026.04.034_bib28","article-title":"IL-18BP is decreased in osteoporotic women: prevents inflammasome mediated IL-18 activation and reduces Th17 differentiation","volume":"6","author":"Mansoori","year":"2017","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.04.034_bib29","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s00774-024-01539-x","article-title":"Crosstalk between bone and the immune system","volume":"42","author":"Okamoto","year":"2024","journal-title":"J. Bone Miner. Metabol."},{"issue":"7","key":"10.1016\/j.bioactmat.2026.04.034_bib30","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/nprot.2017.044","article-title":"Chemically induced mouse models of acute and chronic intestinal inflammation","volume":"12","author":"Wirtz","year":"2017","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.bioactmat.2026.04.034_bib31","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","article-title":"AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis","volume":"156","author":"Ko","year":"2019","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/ecco-jcc\/jjab178","article-title":"ECCO guidelines on therapeutics in ulcerative colitis: medical treatment","volume":"16","author":"Raine","year":"2022","journal-title":"J. Crohns Colitis"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3390\/ijms26010121","article-title":"Key interleukins in inflammatory bowel disease, a review of recent studies","volume":"26","author":"Aebisher","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.bioactmat.2026.04.034_bib34","first-page":"132","article-title":"Signaling pathways associated with bone loss in inflammatory bowel disease","volume":"36","author":"Palatianou","year":"2023","journal-title":"Ann. Gastroenterol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib35","doi-asserted-by":"crossref","first-page":"4506","DOI":"10.1038\/s41467-023-40156-6","article-title":"Macrophage and neutrophil heterogeneity at single-cell spatial resolution in human inflammatory bowel disease","volume":"14","author":"Garrido-Trigo","year":"2023","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41584-023-01053-w","article-title":"Biological and clinical roles of IL-18 in inflammatory diseases","volume":"20","author":"Landy","year":"2024","journal-title":"Nat. Rev. Rheumatol."},{"issue":"7817","key":"10.1016\/j.bioactmat.2026.04.034_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41586-020-2422-6","article-title":"IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy","volume":"583","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.bioactmat.2026.04.034_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252413505","article-title":"IL-18 and IL-18BP: a unique dyad in health and disease","volume":"25","author":"Novick","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.bioactmat.2026.04.034_bib39","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1158\/2326-6066.CIR-23-0706","article-title":"Unleashing natural IL18 activity using an anti-IL18BP blocker induces potent immune stimulation and antitumor effects","volume":"12","author":"Menachem","year":"2024","journal-title":"Cancer Immunol. Res."},{"issue":"5","key":"10.1016\/j.bioactmat.2026.04.034_bib40","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41422-023-00790-7","article-title":"A lncRNA from an inflammatory bowel disease risk locus maintains intestinal host-commensal homeostasis","volume":"33","author":"Ma","year":"2023","journal-title":"Cell Res."},{"issue":"8","key":"10.1016\/j.bioactmat.2026.04.034_bib41","first-page":"3005","article-title":"Interleukin-18 binding protein attenuates renal injury of adriamycin-induced mouse nephropathy","volume":"12","author":"Dong","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010545","article-title":"Weal and woe of interleukin-18 in the T cell therapy of cancer","volume":"13","author":"Kessel","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib43","doi-asserted-by":"crossref","first-page":"qiae172","DOI":"10.1093\/jleuko\/qiae172","article-title":"IL-18 primes T cells with an antigen-inexperienced memory phenotype for proliferation and differentiation into effector cells through notch signaling","volume":"117","author":"Li","year":"2024","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bioactmat.2026.04.034_bib44","article-title":"The effect of cytokines on osteoblasts and osteoclasts in bone remodeling in osteoporosis: a review","volume":"14","author":"Xu","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib45","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/s41392-023-01382-y","article-title":"Engineered exosomes from different sources for cancer-targeted therapy","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"11","key":"10.1016\/j.bioactmat.2026.04.034_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70205","article-title":"The role of extracellular vesicles in musculoskeletal diseases","volume":"14","author":"Fu","year":"2025","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3390\/medicina59010167","article-title":"Matrix metalloproteinase-9 level in synovial fluid-association with joint destruction in early rheumatoid arthritis","volume":"59","author":"Stojanovic","year":"2023","journal-title":"Medicina (Kaunas, Lithuania)"},{"issue":"3","key":"10.1016\/j.bioactmat.2026.04.034_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/ar3857","article-title":"Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis","volume":"14","author":"Mattey","year":"2012","journal-title":"Arthritis Res. Ther."},{"issue":"4","key":"10.1016\/j.bioactmat.2026.04.034_bib49","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s10238-022-00943-9","article-title":"Interleukin 18 and IL-18 BP response to Sars-CoV-2 virus infection","volume":"23","author":"Marino","year":"2023","journal-title":"Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib50","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1038\/s41467-024-48699-y","article-title":"Enhanced CD95 and interleukin 18 signalling accompany T cell receptor V\u03b221.3+ activation in multi-inflammatory syndrome in children","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.bioactmat.2026.04.034_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40635-022-00488-x","article-title":"Elevated free interleukin-18 associated with severity and mortality in prospective cohort study of 206 hospitalised COVID-19 patients","volume":"11","author":"Nasser","year":"2023","journal-title":"Intensive Care Medicine Experimental"}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26002367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26002367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:40:53Z","timestamp":1790408453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26002367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":51,"alternative-id":["S2452199X26002367"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.04.034","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone targeted microenvironment actuated engineered exosomes for precision therapy of IBD associated bone loss","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}